Rezolute (RZLT) Operating Leases (2019 - 2026)

Rezolute (RZLT) reported Operating Leases of $438000.0 for Q1 2026, down 62.24% on a YoY basis from $1.2 million in Q1 2025, and down 29.24% sequentially from $619000.0 in Q4 2025.

Rezolute (RZLT) Operating Leases (2019 - 2026) Analysis & Trends

Rezolute (RZLT) has 8 years of Operating Leases data on file, last reported at $438000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 62.24% year-over-year to $438000.0; the trailing twelve-month figure through Mar 2026 stood at $438000.0 (down 62.24% YoY), and the FY2025 full-year result was $983000.0, down 40.78% from the prior year.
  • Operating Leases eased to $438000.0 in Q1 2026, from $619000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.2 million in Q4 2022 to a low of $49000.0 in Q3 2022.
  • A 5-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases tumbled 69.57% in 2022 and surged 3602.04% in 2023, its largest moves.
  • Tracing RZLT's Operating Leases over 5 years: stood at $2.2 million in 2022, then fell by 10.06% to $2.0 million in 2023, then sank by 32.51% to $1.3 million in 2024, then plunged by 53.56% to $619000.0 in 2025, then retreated by 29.24% to $438000.0 in 2026.
  • Business Quant data shows RZLT's Operating Leases at $438000.0 in Q1 2026, $619000.0 in Q4 2025, and $804000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Rezolute 31,153.77 31,153.77 -

Historic Data

Download Data
DateValue
Mar 31, 2026 438,000.00
Dec 31, 2025 619,000.00
Sep 30, 2025 804,000.00
Jun 30, 2025 983,000.00
Mar 31, 2025 1.16 Mn
Dec 31, 2024 1.33 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 1.66 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 1.98 Mn
Sep 30, 2023 1.81 Mn
Jun 30, 2023 1.94 Mn
Mar 31, 2023 2.06 Mn
Dec 31, 2022 2.20 Mn
Sep 30, 2022 49,000.00
Jun 30, 2022 80,000.00
Mar 31, 2022 107,000.00
Dec 31, 2021 134,000.00
Sep 30, 2021 161,000.00
Jun 30, 2021 187,000.00